Logo image of BRBR

BELLRING BRANDS INC (BRBR) Stock Fundamental Analysis

NYSE:BRBR - US07831C1036 - Common Stock

41.36 USD
+0.49 (+1.2%)
Last: 8/29/2025, 1:27:57 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BRBR. BRBR was compared to 35 industry peers in the Personal Care Products industry. BRBR has an excellent profitability rating, but there are some minor concerns on its financial health. BRBR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

BRBR had positive earnings in the past year.
BRBR had a positive operating cash flow in the past year.
In the past 5 years BRBR has always been profitable.
Each year in the past 5 years BRBR had a positive operating cash flow.
BRBR Yearly Net Income VS EBIT VS OCF VS FCFBRBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

With an excellent Return On Assets value of 22.97%, BRBR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 39.15%, BRBR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BRBR is significantly above the industry average of 12.91%.
The 3 year average ROIC (38.65%) for BRBR is below the current ROIC(39.15%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 22.97%
ROE N/A
ROIC 39.15%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
BRBR Yearly ROA, ROE, ROICBRBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

With an excellent Profit Margin value of 10.26%, BRBR belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
In the last couple of years the Profit Margin of BRBR has declined.
BRBR has a Operating Margin of 16.51%. This is amongst the best in the industry. BRBR outperforms 82.86% of its industry peers.
BRBR's Operating Margin has been stable in the last couple of years.
The Gross Margin of BRBR (35.43%) is worse than 77.14% of its industry peers.
BRBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.51%
PM (TTM) 10.26%
GM 35.43%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
BRBR Yearly Profit, Operating, Gross MarginsBRBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

BRBR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, BRBR has less shares outstanding
The number of shares outstanding for BRBR has been increased compared to 5 years ago.
Compared to 1 year ago, BRBR has an improved debt to assets ratio.
BRBR Yearly Shares OutstandingBRBR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BRBR Yearly Total Debt VS Total AssetsBRBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 6.67 indicates that BRBR is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.67, BRBR belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
BRBR has a debt to FCF ratio of 7.96. This is a slightly negative value and a sign of low solvency as BRBR would need 7.96 years to pay back of all of its debts.
BRBR has a Debt to FCF ratio of 7.96. This is in the better half of the industry: BRBR outperforms 65.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.96
Altman-Z 6.67
ROIC/WACC4.68
WACC8.37%
BRBR Yearly LT Debt VS Equity VS FCFBRBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

2.3 Liquidity

BRBR has a Current Ratio of 2.55. This indicates that BRBR is financially healthy and has no problem in meeting its short term obligations.
BRBR has a Current ratio of 2.55. This is in the better half of the industry: BRBR outperforms 65.71% of its industry peers.
A Quick Ratio of 1.12 indicates that BRBR should not have too much problems paying its short term obligations.
BRBR's Quick ratio of 1.12 is in line compared to the rest of the industry. BRBR outperforms 51.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 1.12
BRBR Yearly Current Assets VS Current LiabilitesBRBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.58% over the past year.
BRBR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.29% yearly.
Looking at the last year, BRBR shows a quite strong growth in Revenue. The Revenue has grown by 16.27% in the last year.
BRBR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.50% yearly.
EPS 1Y (TTM)18.58%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%1.85%
Revenue 1Y (TTM)16.27%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%6.23%

3.2 Future

Based on estimates for the next years, BRBR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.48% on average per year.
Based on estimates for the next years, BRBR will show a quite strong growth in Revenue. The Revenue will grow by 8.36% on average per year.
EPS Next Y16.76%
EPS Next 2Y11.34%
EPS Next 3Y11.99%
EPS Next 5Y10.48%
Revenue Next Year16%
Revenue Next 2Y12.83%
Revenue Next 3Y11.55%
Revenue Next 5Y8.36%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRBR Yearly Revenue VS EstimatesBRBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
BRBR Yearly EPS VS EstimatesBRBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

BRBR is valuated rather expensively with a Price/Earnings ratio of 19.06.
Based on the Price/Earnings ratio, BRBR is valued a bit cheaper than 77.14% of the companies in the same industry.
BRBR is valuated rather cheaply when we compare the Price/Earnings ratio to 27.17, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 17.29, BRBR is valued on the expensive side.
71.43% of the companies in the same industry are more expensive than BRBR, based on the Price/Forward Earnings ratio.
BRBR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.06
Fwd PE 17.29
BRBR Price Earnings VS Forward Price EarningsBRBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRBR is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRBR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 41.12
EV/EBITDA 15.85
BRBR Per share dataBRBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

BRBR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BRBR may justify a higher PE ratio.
PEG (NY)1.14
PEG (5Y)N/A
EPS Next 2Y11.34%
EPS Next 3Y11.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BRBR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BELLRING BRANDS INC

NYSE:BRBR (8/29/2025, 1:27:57 PM)

41.36

+0.49 (+1.2%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-18 2025-11-18/amc
Inst Owners100.93%
Inst Owner Change2.05%
Ins Owners1.28%
Ins Owner Change-0.39%
Market Cap5.21B
Analysts81.74
Price Target57.39 (38.76%)
Short Float %3.99%
Short Ratio1.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.74%
Min EPS beat(2)-0.84%
Max EPS beat(2)8.31%
EPS beat(4)3
Avg EPS beat(4)6.72%
Min EPS beat(4)-0.84%
Max EPS beat(4)18.96%
EPS beat(8)7
Avg EPS beat(8)11.06%
EPS beat(12)11
Avg EPS beat(12)10.83%
EPS beat(16)14
Avg EPS beat(16)11.54%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-0.33%
Max Revenue beat(2)1.03%
Revenue beat(4)2
Avg Revenue beat(4)0.46%
Min Revenue beat(4)-0.52%
Max Revenue beat(4)1.64%
Revenue beat(8)5
Avg Revenue beat(8)1.26%
Revenue beat(12)7
Avg Revenue beat(12)0.65%
Revenue beat(16)8
Avg Revenue beat(16)-0.21%
PT rev (1m)-28.23%
PT rev (3m)-33.61%
EPS NQ rev (1m)-8.09%
EPS NQ rev (3m)-5.4%
EPS NY rev (1m)0.46%
EPS NY rev (3m)0.62%
Revenue NQ rev (1m)-2.34%
Revenue NQ rev (3m)2.07%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE 19.06
Fwd PE 17.29
P/S 2.34
P/FCF 41.12
P/OCF 39.59
P/B N/A
P/tB N/A
EV/EBITDA 15.85
EPS(TTM)2.17
EY5.25%
EPS(NY)2.39
Fwd EY5.78%
FCF(TTM)1.01
FCFY2.43%
OCF(TTM)1.04
OCFY2.53%
SpS17.66
BVpS-2.46
TBVpS-4.01
PEG (NY)1.14
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 22.97%
ROE N/A
ROCE 52.23%
ROIC 39.15%
ROICexc 41.74%
ROICexgc 59.28%
OM 16.51%
PM (TTM) 10.26%
GM 35.43%
FCFM 5.7%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
ROICexc(3y)42.57%
ROICexc(5y)39.59%
ROICexgc(3y)77.99%
ROICexgc(5y)768.49%
ROCE(3y)51.56%
ROCE(5y)45.04%
ROICexcg growth 3Y-71.38%
ROICexcg growth 5Y-2%
ROICexc growth 3Y6.3%
ROICexc growth 5Y16.08%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
F-Score5
Asset Turnover2.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.96
Debt/EBITDA 2.62
Cap/Depr 26.49%
Cap/Sales 0.22%
Interest Coverage 250
Cash Conversion 34.11%
Profit Quality 55.5%
Current Ratio 2.55
Quick Ratio 1.12
Altman-Z 6.67
F-Score5
WACC8.37%
ROIC/WACC4.68
Cap/Depr(3y)6.58%
Cap/Depr(5y)6.2%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.13%
Profit Quality(3y)77.59%
Profit Quality(5y)290.17%
High Growth Momentum
Growth
EPS 1Y (TTM)18.58%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%1.85%
EPS Next Y16.76%
EPS Next 2Y11.34%
EPS Next 3Y11.99%
EPS Next 5Y10.48%
Revenue 1Y (TTM)16.27%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%6.23%
Revenue Next Year16%
Revenue Next 2Y12.83%
Revenue Next 3Y11.55%
Revenue Next 5Y8.36%
EBIT growth 1Y3.85%
EBIT growth 3Y32.15%
EBIT growth 5Y18.99%
EBIT Next Year23.76%
EBIT Next 3Y15.36%
EBIT Next 5Y9.6%
FCF growth 1Y-8.65%
FCF growth 3Y-4.13%
FCF growth 5Y15.77%
OCF growth 1Y-6.2%
OCF growth 3Y-4.07%
OCF growth 5Y15.22%